This invention is directed to substituted aryl compounds, which are linked to a substituted indole moiety by various linkers, and the kynurenine/kynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing these compounds. This invention further is directed to the pharmaceutical use of the compounds for inhibiting GSK3β kinase and/or modulating N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.
本发明涉及取代芳基化合物,其通过各种连接剂与取代
吲哚基团相连,并且这些药剂的酮尿
氨酸/酮尿
胺类似物以及它们的制备和含有这些化合物的药物组合物。本发明进一步涉及这些化合物用于抑制GSK3β激酶和/或调节
N-甲基-D-天冬氨酸(N
MDA)通道活性,用于治疗神经退行性和其他疾病的药物用途。